Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients ...

Scientists investigated how an inherited genetic variation common among East Asians contributes to drug resistance in cancer cells, driving more aggressive cancer growth. The team trialled a precision ...

The medicine - branded Lenvima - stops cancer cells from multiplying, slowing the disease's progression.

In 2020, leukemia (cancer of the blood) accounted for approximately 2.5 per cent of all new cancer cases and 3.1 per cent of deaths globally. Of these, chronic myeloid leukemia (CML) is a subtype that ...

These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...